Anika Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ANIK 42.35 +0.63 (1.51%)
price chart
Why Anika Therapeutics Inc. Shares Skyrocketed
What: Shares of Anika Therapeutics (NASDAQ:ANIK), a biopharmaceutical company focused on developing therapies for tissue protection, healing, and repair, jumped as much as 52% after the Food and Drug Administration gave marketing approval for the ...
, A New Single Injection Treatment for Treatment of Pain Due to ...  Business Wire (press release)
What does the approval of Monovisc mean for Anika Therapeutics?  Boston Business Journal (blog)
Related articles »  
Anika Therapeutics Inc. ANIK (US: Nasdaq)
News Anika Therapeutics Inc.ANIK. Significant News Only. 02/28/17; Press Release. Anika to Present at the 2017 Canaccord Genuity Musculoskeletal Conference on March 14, 2017.
Why Anika Therapeutics Gained 13% in July
Anika pleased investors during the month by reporting second-quarter earnings of $0.51 per-share, which was well ahead of the $0.34 that analysts were expecting.
Breaking Down: Anika Therapeutics Inc (NASDAQ:ANIK) Stock Drop Below Support ...
Anika Therapeutics Inc has a one bull (extreme weakness) technical rating because it's trading below the 10 day, 50 day and 200 day simple moving averages while the 10-day moving average is below the 50-day moving average and the 50-day moving ...
Anika Therapeutics' (ANIK) CEO Charles Sherwood on Q4 2016 Results - Earnings ...
Good day, ladies and gentlemen and welcome to Anika Therapeutics Fourth Quarter and Year-End Earnings Conference Call. At that time ... The company's actual results could differ materially from any anticipated future results, performance or achievements.
Stock Returns: Anika Therapeutics Inc (NASDAQ:ANIK) versus Haemonetics ...  CML News
Anika Therapeutics Inc. (ANIK) Moves Lower on Volume Spike for February 17  Equities.com
Anika Therapeutics, Inc. Announces First Patient Enrolled in FastTRACK Phase ...
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced the enrollment of the ...
Implied Volatility Surging for Anika Therapeutics (ANIK) Stock Options
Investors in shares of Anika Therapeutics, Inc. ANIK need to pay close attention to the stock based on moves in the options market lately.
The Anika Therapeutics Inc (ANIK) Stake Held by Public Sector Pension ...
Public Sector Pension Investment Board maintained its position in Anika Therapeutics Inc (NASDAQ:ANIK) during the fourth quarter, Holdings Channel reports.
AQR Capital Management LLC Has $5566000 Position in Anika Therapeutics Inc ...  Sports Perspectives
-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid “HA” technology, today announced that it received CE ...
Anika Therapeutics, Inc Surges On Approval, but Is It Overpriced Now?
Anika (NASDAQ:ANIK) jumped by a third following the FDA's approval of Monovisc, its single injection treatment for osteoarthritis knee pain.
Related articles »